tiprankstipranks
Trending News
More News >

Recordati Updates on Share Buyback Program Execution

Story Highlights
  • Recordati is a global pharmaceutical company offering specialty and general medicine.
  • Recordati executed a share buyback, acquiring 90,057 shares to support management plans.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Recordati Updates on Share Buyback Program Execution

Don’t Miss TipRanks’ Half-Year Sale

Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an update.

Recordati S.p.A. has updated its shareholders on the execution of its share buyback program, which was initiated to support stock options and performance share plans for the company’s management. The company purchased a total of 90,057 ordinary shares between June 23 and June 27, 2025, increasing its total holdings to 3,563,650 shares, representing 1.704% of its share capital.

The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, and operates in about 150 countries across the EMEA, Americas, and APAC regions with over 4,580 employees.

Average Trading Volume: 355,474

Technical Sentiment Signal: Strong Buy

Current Market Cap: €11.15B

See more data about REC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1